• Medox and possible mitigating effect on Cancer (in vitro, human brain-tumor): “Indremedisinsk Institutt”, University of Bergen (UIB), 2004.
  • Effect of the Medox® C3G single molecule against Melanoma skin cancer; Institute of Neurobiology and Molecular Medicine, National Research Council, Roma, Italy; ”The Journal of Federation of American Societies for Experimental Biology”, USA-2004, Cancer.
  • Pilot trial, 8 persons on Medox® and possible influence on Inflammation (CRP), Ullevål University hospital, Oslo.
  • Pilot trial, 10 persons on Medox® and possible influence on Inflammation (CRP), Ullevål University hospital, Oslo.
  • Pilot trial, Institute of Experimental Medical research on Medox®, resting pulse and Ischemia. Ullevål University hospital, Oslo.
  • Medox® and possible influence on resting pulse, immune defence, sedimentation and colds. Randomized, double blind, placebo controlled, n =120, Ullevål University Hospital, Oslo.
  • Absorption, penetration and metabolism of Medox® in oral consumption, Stavanger University hospital.
  • Clinical trial on Medox® and Chronic Inflammation (NF-KappaB + + +). Randomized, double blind, placebo controlled, n=119, Ullevål University Hospital and the University of Oslo. Finansced by the Norwegioan Cancer Society, The Norwegian Research Council and The Throne Holst Research Fund. Published in “ The Journal of Nutrition”, USA, July 26, 2007.
  • Medox® anthocyanin molecules and their influence on Chronic Inflammation (NF-Kappa-B), n=120, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, PR China, Sun Yat-sen University in China, published in ” Arteriosclerosis, Thrombosis and Vascular Biology” April, 2007, USA.
  • Medox® type C3G -molecule possible effects on iNOS and COX-2. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 by inducing liver receptor alpha alpha activation in THP-1 macrophages. “Life Science”, June 18, 2008 18619979 (P,S, G, E, B, D. Wenhua Ling et al. Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou 510080, PR China.
  • Medox® and oxidative stress on elderly female (small in vivo pilot trial), Dr. Med. M. Nylander, nutrition researcher, Stockholm, Sweden.
  • Effects of Medox® against oxidative stress on top ski cross country athlets during periods of vigorous exercise (small in vivo pilot trial), Dr. Med. M. Nylander, nutrition researcher, Stockholm, Sweden.
  • Effects of Medox® against oxidative stress on rheumatics (small in vivo pilot trial), Dr. Med. M. Nylander, nutrition researcher, Stockholm, Sweden.
  • Some studies on the effects of Medox on resting heart rate and blood pressure (in vivo pilot, rat study, placebo controlled), Ullevål University Hospital, Oslo.
  • Study on the effect of Medox® single anthocyanin molecules C 3G/D 3G on resting heart rate and blood pressure (placebo controlled rat study), Ullevål University Hospital, Oslo.
  • Study on the effect of Medox® single anthocyanin molecules C 3G/D 3G on: Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer and Bladder Cancer(in vitro, humane cancer cell lines), Apoptosis, Necrosis and Autoschises.: Summa Health Center, Cleveland, Ohio, USA.
  • Effects of Medox® on kidney failure and oxsidative stress (randomized, double blind, placebo controlled, 40 persons with kidney failure), Karolinska University Hospital, Stockholm, Sweden.
  • R&D on Biolink Group anthocyanin molecules as basis for non-biopsy diagnostics on female humans and bovine animals, Harvard University, Cambridge, Massachusetts, USA 2005.
  • Effects of Medox® against the Metabolic Syndrome. Study of LDL, HDL, CETP and TAC (human, randomized, double blind, placebo controlled study, n>120, Sun Yat-sen University, Peoples Republic of China, Published in ”The American Journal of Clinical Nutrition” USA in 2009.
  • Effects of Medox® against the Metabolic Syndrome and characteristic parameters for the cardiovasculøar system (human, randomized, double blind, placebo controlled study, n>120), Sun Yat-sen University, Peoples Republic of China 2008-2010.
  • Effects of the Medox® single molecule C 3G related to obesity and the relevance of applying the C 3G anthocyanin in «Functional Food», Sun Yat-sen University, Peoples Republic of China. Published in «The Journal of Science and Food Agriculture», USA, 2010.
  • The effects of the Medox® single anthocyanin molecule C 3G related to Inflammation, Oxsidative Stress and Cardiovascular Diseases, The University of Messina and National Research Institute for Food and Nutrition in Roma, Italy. Published in «The Journal of Agriculture Food & Chemistry», USA, 2010.
  • Study of Medox® anthocyanin molecules and their potential influence on neurological diseases, ”A human inherited metabolic disorder that is associated with a defect in peroxisome metabolism”, School of Medicine, Johns Hopkins University, USA 2009.
  • Medox® and possible influence on stomach cancer (Gastric Cancer, GC). In vivo study at The University of Gothenburg. Part of a long term international study including participating cancer researchers from Sweden, USA, Canada and Nicaragua being evaluated.
  • Effect of Medox® on Cardiovascular Diseases. Emphasis on the arteries most important functions. Sun Yat-sen University, Peoples Republic of China. Published in ”Clinical Chemistry” USA 2011.
  • Effect of the Medox® single molecule C 3G on Cardiovascular Diseases, Sun Yat-sen University, Peoples Republic of China. Published in “Molecular & Cellular Biochemistry”, USA, 2011.
  • Effect of the Medox® single molecule C 3G on Hepatic Injury and diabetes 2. Sun Yat-sen University, Peoples Republic of China. Published in «The Journal of Lipid Research», USA 2011.
  • Anti-inflammatory effects of Medox® anthocyanin single molecules C 3G and D 3G in adults with an elevated level of cholesterol, Sun Yat-sen University, Peoples Republic of China. Published in «Nutrition, Metabolism & Cardiovascular Diseases», USA 2012.
  • Clinical, human, randomized, double blind, placebo controlled cardiovascular study on Medox®, University of Messina in Italy. Special emphasis on: Vascular Inflammation and Artherosclerosis and Endothelial activation. Published in «Genes & Nutrition»; New York USA/Heidelberg Germany, 2012.